2017-06-12 |
2017-06-09 |
A
Achat
|
Trieu Vuong
Chairman of the Board
Administrateur exécutif
Actionnaire important
|
10 000
+0.1%
0,39
3 900 USD
|
10 000
+0.1%
|
0,39
|
3 900 USD
|
|
2017-06-08 |
2017-06-08 |
A
Achat
|
Trieu Vuong
Chairman of the Board
Administrateur exécutif
Actionnaire important
|
20 000
+0.2%
0,39
7 800 USD
|
20 000
+0.2%
|
0,39
|
7 800 USD
|
|
2017-06-08 |
2017-06-07 |
A
Achat
|
Trieu Vuong
Chairman of the Board
Administrateur exécutif
Actionnaire important
|
2 500
+0.0%
0,38
950 USD
|
2 500
+0.0%
|
0,38
|
950 USD
|
|
2017-04-07 |
2017-04-07 |
A
Achat
|
Ramelli Joseph W.
Chief Executive Officer
|
22 500
+5.4%
0,43
9 563 USD
|
22 500
+5.4%
|
0,43
|
9 563 USD
|
|
2017-04-07 |
2017-04-06 |
A
Achat
|
Ramelli Joseph W.
Chief Executive Officer
|
13 000
+3.2%
0,34
4 368 USD
|
13 000
+3.2%
|
0,34
|
4 368 USD
|
|
2017-04-05 |
2017-04-05 |
A
Achat
|
Ramelli Joseph W.
Chief Executive Officer
|
97 550
+31.7%
0,31
30 436 USD
|
97 550
+31.7%
|
0,31
|
30 436 USD
|
|
2017-02-08 |
2017-02-06 |
A
Achat
|
Trieu Vuong
Chairman of the Board
Administrateur exécutif
Actionnaire important
|
862 068
+inf%
0,29
250 000 USD
|
862 068
+inf%
|
0,29
|
250 000 USD
|
|
2014-04-18 |
2014-04-16 |
A
Achat
|
Ramelli Joseph W.
Administrateur non-exécutif
|
26 300
+14.5%
0,76
19 999 USD
|
26 300
+14.5%
|
0,76
|
19 999 USD
|
|
2014-02-10 |
2014-02-10 |
V
Vente
|
Pryor Cashman LLP
Actionnaire important
|
15 000
-0.9%
1,02
15 270 USD
|
15 000
-0.9%
|
1,02
|
15 270 USD
|
|
2014-02-10 |
2014-02-07 |
V
Vente
|
Pryor Cashman LLP
Actionnaire important
|
59 000
-3.5%
1,01
59 413 USD
|
59 000
-3.5%
|
1,01
|
59 413 USD
|
|
2014-02-10 |
2014-02-06 |
V
Vente
|
Pryor Cashman LLP
Actionnaire important
|
34 041
-2.0%
0,95
32 305 USD
|
34 041
-2.0%
|
0,95
|
32 305 USD
|
|
2013-10-04 |
2013-10-04 |
V
Vente
|
Pryor Cashman LLP
Actionnaire important
|
35 000
-2.0%
0,24
8 334 USD
|
35 000
-2.0%
|
0,24
|
8 334 USD
|
|
2013-10-04 |
2013-10-03 |
V
Vente
|
Pryor Cashman LLP
Actionnaire important
|
65 000
-3.6%
0,25
16 335 USD
|
65 000
-3.6%
|
0,25
|
16 335 USD
|
|
2011-01-27 |
2011-01-26 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
3 780
-0.2%
1,21
4 574 USD
|
3 780
-0.2%
|
1,21
|
4 574 USD
|
|
2011-01-27 |
2011-01-26 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
2 056
-0.1%
1,20
2 467 USD
|
2 056
-0.1%
|
1,20
|
2 467 USD
|
|
2011-01-27 |
2011-01-26 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
10 730
-0.4%
1,19
12 769 USD
|
10 730
-0.4%
|
1,19
|
12 769 USD
|
|
2011-01-27 |
2011-01-26 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
16 784
-0.7%
1,18
19 805 USD
|
16 784
-0.7%
|
1,18
|
19 805 USD
|
|
2011-01-27 |
2011-01-26 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
19 550
-0.8%
1,17
22 874 USD
|
19 550
-0.8%
|
1,17
|
22 874 USD
|
|
2011-01-27 |
2011-01-26 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
10 700
-0.4%
1,16
12 412 USD
|
10 700
-0.4%
|
1,16
|
12 412 USD
|
|
2011-01-27 |
2011-01-26 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
1 900
-0.1%
1,15
2 185 USD
|
1 900
-0.1%
|
1,15
|
2 185 USD
|
|
2011-01-27 |
2011-01-26 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
1 300
-0.1%
1,14
1 482 USD
|
1 300
-0.1%
|
1,14
|
1 482 USD
|
|
2011-01-27 |
2011-01-26 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
2 600
-0.1%
1,13
2 938 USD
|
2 600
-0.1%
|
1,13
|
2 938 USD
|
|
2011-01-27 |
2011-01-26 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
1 200
-0.0%
1,12
1 344 USD
|
1 200
-0.0%
|
1,12
|
1 344 USD
|
|
2011-01-27 |
2011-01-26 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
1 800
-0.1%
1,11
1 998 USD
|
1 800
-0.1%
|
1,11
|
1 998 USD
|
|
2011-01-27 |
2011-01-26 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
400
-0.0%
1,10
440 USD
|
400
-0.0%
|
1,10
|
440 USD
|
|
2011-01-27 |
2011-01-26 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
700
-0.0%
1,09
763 USD
|
700
-0.0%
|
1,09
|
763 USD
|
|
2011-01-27 |
2011-01-26 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
1 000
-0.0%
1,08
1 080 USD
|
1 000
-0.0%
|
1,08
|
1 080 USD
|
|
2011-01-27 |
2011-01-25 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
700
-0.0%
1,20
840 USD
|
700
-0.0%
|
1,20
|
840 USD
|
|
2011-01-27 |
2011-01-25 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
400
-0.0%
1,18
472 USD
|
400
-0.0%
|
1,18
|
472 USD
|
|
2011-01-27 |
2011-01-25 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
670
-0.0%
1,17
784 USD
|
670
-0.0%
|
1,17
|
784 USD
|
|
2011-01-27 |
2011-01-25 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
1 530
-0.1%
1,16
1 775 USD
|
1 530
-0.1%
|
1,16
|
1 775 USD
|
|
2011-01-27 |
2011-01-25 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
19 200
-0.7%
1,15
22 080 USD
|
19 200
-0.7%
|
1,15
|
22 080 USD
|
|
2011-01-27 |
2011-01-25 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
9 005
-0.3%
1,14
10 266 USD
|
9 005
-0.3%
|
1,14
|
10 266 USD
|
|
2011-01-27 |
2011-01-25 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
5 100
-0.2%
1,13
5 763 USD
|
5 100
-0.2%
|
1,13
|
5 763 USD
|
|
2011-01-27 |
2011-01-25 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
15 100
-0.6%
1,12
16 912 USD
|
15 100
-0.6%
|
1,12
|
16 912 USD
|
|
2011-01-27 |
2011-01-25 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
600
-0.0%
1,12
669 USD
|
600
-0.0%
|
1,12
|
669 USD
|
|
2011-01-27 |
2011-01-25 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
26 200
-1.0%
1,11
29 082 USD
|
26 200
-1.0%
|
1,11
|
29 082 USD
|
|
2011-01-27 |
2011-01-25 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
12 000
-0.5%
1,10
13 200 USD
|
12 000
-0.5%
|
1,10
|
13 200 USD
|
|
2011-01-27 |
2011-01-25 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
2 500
-0.1%
1,09
2 725 USD
|
2 500
-0.1%
|
1,09
|
2 725 USD
|
|
2011-01-25 |
2011-01-24 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
6 510
-0.2%
1,22
7 942 USD
|
6 510
-0.2%
|
1,22
|
7 942 USD
|
|
2011-01-25 |
2011-01-24 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
100
-0.0%
1,21
121 USD
|
100
-0.0%
|
1,21
|
121 USD
|
|
2011-01-25 |
2011-01-24 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
23 800
-0.9%
1,21
28 798 USD
|
23 800
-0.9%
|
1,21
|
28 798 USD
|
|
2011-01-25 |
2011-01-24 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
600
-0.0%
1,21
723 USD
|
600
-0.0%
|
1,21
|
723 USD
|
|
2011-01-25 |
2011-01-24 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
400
-0.0%
1,20
481 USD
|
400
-0.0%
|
1,20
|
481 USD
|
|
2011-01-25 |
2011-01-24 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
17 907
-0.7%
1,20
21 488 USD
|
17 907
-0.7%
|
1,20
|
21 488 USD
|
|
2011-01-25 |
2011-01-24 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
3 883
-0.1%
1,19
4 621 USD
|
3 883
-0.1%
|
1,19
|
4 621 USD
|
|
2011-01-25 |
2011-01-24 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
14 200
-0.5%
1,18
16 756 USD
|
14 200
-0.5%
|
1,18
|
16 756 USD
|
|
2011-01-25 |
2011-01-24 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
3 000
-0.1%
1,17
3 510 USD
|
3 000
-0.1%
|
1,17
|
3 510 USD
|
|
2011-01-25 |
2011-01-24 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
2 100
-0.1%
1,16
2 436 USD
|
2 100
-0.1%
|
1,16
|
2 436 USD
|
|
2011-01-25 |
2011-01-24 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
300
-0.0%
1,15
345 USD
|
300
-0.0%
|
1,15
|
345 USD
|
|
2011-01-25 |
2011-01-21 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
200
-0.0%
1,30
260 USD
|
200
-0.0%
|
1,30
|
260 USD
|
|
2011-01-25 |
2011-01-21 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
300
-0.0%
1,29
387 USD
|
300
-0.0%
|
1,29
|
387 USD
|
|
2011-01-25 |
2011-01-21 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
900
-0.0%
1,28
1 152 USD
|
900
-0.0%
|
1,28
|
1 152 USD
|
|
2011-01-25 |
2011-01-21 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
5 935
-0.2%
1,27
7 537 USD
|
5 935
-0.2%
|
1,27
|
7 537 USD
|
|
2011-01-25 |
2011-01-21 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
22 865
-0.8%
1,26
28 810 USD
|
22 865
-0.8%
|
1,26
|
28 810 USD
|
|
2011-01-25 |
2011-01-21 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
34 200
-1.2%
1,25
42 750 USD
|
34 200
-1.2%
|
1,25
|
42 750 USD
|
|
2011-01-25 |
2011-01-21 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
4 900
-0.2%
1,24
6 076 USD
|
4 900
-0.2%
|
1,24
|
6 076 USD
|
|
2011-01-25 |
2011-01-21 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
200
-0.0%
1,23
246 USD
|
200
-0.0%
|
1,23
|
246 USD
|
|
2011-01-21 |
2011-01-20 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
1 000
-0.0%
1,50
1 500 USD
|
1 000
-0.0%
|
1,50
|
1 500 USD
|
|
2011-01-21 |
2011-01-20 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
100
-0.0%
1,49
149 USD
|
100
-0.0%
|
1,49
|
149 USD
|
|
2011-01-21 |
2011-01-20 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
4 500
-0.2%
1,46
6 570 USD
|
4 500
-0.2%
|
1,46
|
6 570 USD
|
|
2011-01-21 |
2011-01-20 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
4 400
-0.2%
1,43
6 292 USD
|
4 400
-0.2%
|
1,43
|
6 292 USD
|
|
2011-01-21 |
2011-01-20 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
2 800
-0.1%
1,42
3 976 USD
|
2 800
-0.1%
|
1,42
|
3 976 USD
|
|
2011-01-21 |
2011-01-20 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
1 500
-0.1%
1,41
2 115 USD
|
1 500
-0.1%
|
1,41
|
2 115 USD
|
|
2011-01-21 |
2011-01-20 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
5 200
-0.2%
1,40
7 280 USD
|
5 200
-0.2%
|
1,40
|
7 280 USD
|
|
2011-01-21 |
2011-01-20 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
4 500
-0.2%
1,39
6 255 USD
|
4 500
-0.2%
|
1,39
|
6 255 USD
|
|
2011-01-21 |
2011-01-20 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
6 292
-0.2%
1,38
8 683 USD
|
6 292
-0.2%
|
1,38
|
8 683 USD
|
|
2011-01-21 |
2011-01-20 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
208
-0.0%
1,37
285 USD
|
208
-0.0%
|
1,37
|
285 USD
|
|
2011-01-21 |
2011-01-20 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
2 700
-0.1%
1,35
3 645 USD
|
2 700
-0.1%
|
1,35
|
3 645 USD
|
|
2011-01-21 |
2011-01-20 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
2 057
-0.1%
1,33
2 736 USD
|
2 057
-0.1%
|
1,33
|
2 736 USD
|
|
2011-01-21 |
2011-01-20 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
1 943
-0.1%
1,32
2 565 USD
|
1 943
-0.1%
|
1,32
|
2 565 USD
|
|
2011-01-21 |
2011-01-20 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
2 500
-0.1%
1,31
3 275 USD
|
2 500
-0.1%
|
1,31
|
3 275 USD
|
|
2011-01-21 |
2011-01-20 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
2 000
-0.1%
1,30
2 600 USD
|
2 000
-0.1%
|
1,30
|
2 600 USD
|
|
2011-01-21 |
2011-01-20 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
200
-0.0%
1,29
258 USD
|
200
-0.0%
|
1,29
|
258 USD
|
|
2011-01-21 |
2011-01-20 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
1 000
-0.0%
1,27
1 270 USD
|
1 000
-0.0%
|
1,27
|
1 270 USD
|
|